VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CCRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CCRNCross Country Healthcare, Inc.
$13.21$427M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCCRNBalance Sheet

Cross Country Healthcare, Inc. (CCRN) Balance Sheet

27Y historyFree accessUpdated daily

The company maintains a pristine capital structure with total debt of only $2.0M and a robust current ratio of 3.29 as of 2026Q1, providing significant insulation against market volatility.

CCRN Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Total Current Assets298.3M293.59M335M415.15M675.67M508.27M183.11M183.36M194.91M208.89M205.61M158.75M131.18M83.94M145.37M104.81M104.41M106.21M161.38M149.14M146.23M140.75M116.69M127.29M128.08M105.06M76.7M4.83M
Cash & Short-Term Investments105.58M108.74M81.63M17.09M3.6M1.04M1.6M1.03M16.02M25.54M20.63M2.45M5M8.05M10.46M12.34M12.83M8.6M10.17M9.07M000017.21M2.64M04.83M
Cash Only105.58M108.74M81.63M17.09M3.6M1.04M1.6M1.03M16.02M25.54M20.63M2.45M5M8.05M10.46M10.65M10.96M8.6M10.17M9.07M000017.21M2.64M04.83M
Short-Term Investments0000000000000001.69M1.87M00000000000
Accounts Receivable184.05M167.51M242.88M388.35M659.96M498.95M174.7M174.54M170.31M177.1M176.66M149.74M119.06M68.92M63.26M73.68M72.61M78.45M119.22M116.56M116.34M110.54M98.54M114.72M97.64M88.93M67.16M0
Days Sales Outstanding69.1857.9965.9670.1885.93108.6276.2477.4876.1474.7377.3671.2270.3457.452.1653.3656.5649.5259.2759.2364.8162.5254.9960.9555.6964.8566.67-
Inventory000011.07M0006.21M5.29M6.13M4.52M6.07M6.16M65.11M18.09M11.8M3.19M30.21M21.16M00004.68M8.39M00
Days Inventory Outstanding----1.85---3.733.033.652.894.826.9271.7918.0312.812.7720.3614.2----3.578.17--
Other Current Assets1.26M17.34M2.64M2.03M1.04M638K1.35M1.69M2.36M963K2.2M2.03M1.05M8.97M54M11.35M12.45M12.46M13.06M8.96M26.05M26.8M14.74M9.05M9.41M9.5M6.23M0
Total Non-Current Assets152.77M155.36M254.25M264.16M272.17M224.54M173.86M199.02M232.1M258.8M182.77M207.35M193.95M164.65M160.56M231.1M243.79M250.38M264.47M386.17M357.81M340.91M339.31M347.43M262.52M256.92M240.92M0
Property, Plant & Equipment29.09M29.98M31.32M29.94M22.92M23.38M22.9M28.94M13.63M14.09M12.82M10.47M12.13M6.17M8.23M12.02M14.54M19.71M25.98M23.46M20.56M16.48M11.84M12.6M12.39M11.4M6.17M0
Fixed Asset Turnover33.56x35.17x42.91x67.46x122.33x71.72x36.52x28.41x59.91x61.41x65.03x73.30x50.92x71.04x53.75x41.94x32.23x29.34x28.26x30.62x31.86x39.17x55.25x54.51x51.63x43.91x59.61x-
Goodwill63.8M63.8M135.06M135.43M163.27M119.49M90.92M101.07M101.06M117.59M79.65M95.1M90.65M77.47M62.71M143.34M143.35M130.7M122.6M326.12M310.17M302.85M302.85M00000
Intangible Assets40.91M27.64M42.19M54.47M44.72M48.24M40.73M50.86M75.58M87.68M72.24M82.91M72.02M68.3M63.19M73.25M76.74M91.43M96.9M35.15M26.51M20.89M22.31M331.86M248.98M244.05M226.01M0
Long-Term Investments60.25M14.86M033K23.78M14.67M0016.19M17.2M16.21M17.99M010.91M0-10.64B2.11M1.54M0-6.17B-10.99B-7.64B-4.95B-1.93B-645.18M000
Other Non-Current Assets1.76M19.08M37.58M38.34M10.38M7.23M19.31M18.15M1.89M2.03M507K-88K19.15M1.46M10.23M1.29M4.58M1.62M3.92M1.44M562.89K689.11K2.3M2.97M1.15M1.47M8.75M0
Total Assets451.07M448.95M589.25M679.32M947.84M732.81M356.97M382.37M427M467.69M388.38M366.1M325.13M248.58M305.92M335.91M348.21M356.59M425.85M535.31M504.03M481.66M455.99M474.72M390.6M361.98M317.63M309.69M
Asset Turnover2.01x2.35x2.28x2.97x2.96x2.29x2.34x2.15x1.91x1.85x2.15x2.10x1.90x1.76x1.45x1.50x1.35x1.62x1.72x1.34x1.30x1.34x1.43x1.45x1.64x1.38x1.16x0.63x
Asset Growth %-63.58%-23.81%-13.26%-28.33%29.34%105.28%-6.64%-10.45%-8.7%20.42%6.09%12.6%30.79%-18.74%-8.93%-3.53%-2.35%-16.26%-20.45%6.21%4.64%5.63%-3.95%21.54%7.91%13.96%2.56%-
Total Current Liabilities90.57M77.76M120.4M148.59M271.64M199.77M93.42M85.47M85.39M94.59M97.09M86.05M67M44.71M72.59M46.35M36.9M34.56M56.28M50.41M66.12M69.88M44.76M47.76M49.93M35.9M42.33M0
Accounts Payable47.6M46.03M5.74M3.04M12.86M109.75M49.88M45.73M43.74M50.6M43.36M41.1M27.31M10.27M10.13M9.02M0012.44M10.2M13.74M12.08M5.99M9.46M3.3M1.97M6.45M0
Days Payables Outstanding21.0119.591.960.712.1530.7828.732726.3129.0225.8726.3121.6711.5411.178.99--8.386.859.988.774.296.642.511.928.61-
Short-Term Debt974K1.16M0008.27M2.42M05.24M6.88M2.26M8.07M3.61M8.48M33.68M17M7.96M5.73M15.83M5.07M1.55M5.48M2.41M4.94M14.36M3.79M12.88M0
Deferred Revenue (Current)0000000033.33M34.27M33.24M34M33.28M21.89M21.65M00021.33M26.1M44.89M47.94M32.03M29.99M29.66M28.31M21.23M0
Other Current Liabilities2.47M30.56M28.76M127M154.98M8.86M12.66M14.38M3.08M2.85M2.75M7.47M2.79M4.4M7.12M4.11M3.74M4.54M6.68M7.82M12.64M4.38M4.33M3.36M2.38M1.83M1.76M0
Current Ratio3.29x3.78x2.78x2.79x2.49x2.54x1.96x2.15x2.28x2.21x2.12x1.84x1.96x1.88x2.00x2.26x2.83x3.07x2.87x2.96x2.21x2.01x2.61x2.67x2.57x2.93x1.81x-
Quick Ratio3.29x3.78x2.78x2.79x2.45x2.54x1.96x2.15x2.21x2.15x2.05x1.79x1.87x1.74x1.11x1.87x2.51x2.98x2.33x2.54x2.21x2.01x2.61x2.67x2.47x2.69x1.81x-
Cash Conversion Cycle48.17---85.63---53.5648.7455.1447.853.4852.78112.7962.4--71.2466.59----56.7571.11--
Total Non-Current Liabilities47.7M48.37M49.89M57.34M218.98M235.51M108.64M133.41M123.42M135.38M139.48M138.71M127.81M25.82M24.21M40.26M65.3M75.96M135.54M94.46M63.06M52.49M64.86M106.44M39.84M56.15M151.96M0
Long-Term Debt0000148.74M176.37M55.83M70.97M77.94M92.26M84.75M81.3M70.47M93K176K25.05M45.56M56.78M115.11M34.38M19.98M19.95M39.87M88.79M28.45M45.08M144.39M0
Capital Lease Obligations5.04M1.16M1.78M2.66M4.88M10.85M15.23M19.07M0010K000000405.2K2.14M001.2M86.79K00000
Deferred Tax Liabilities5.22M2.52M566K401K247K190K6.59M7.52M95K105K13.15M18.48M18.04M16.85M16.18B58K2.48B5.39B15.06B49.55M43.08M32.55M25M17.65M10.78M8.57M7.57M0
Other Non-Current Liabilities43.93M44.7M47.54M54.27M65.12M48.1M30.98M35.84M45.38M43.02M41.57M38.93M39.3M25.73M24.04M15.15M16.78M18.78M18.29M10.83M0-1.2M-86.79K0606.36K2.51M00
Total Liabilities138.27M126.13M170.29M205.92M490.62M435.28M202.06M218.87M208.81M229.97M236.58M224.75M194.8M70.53M96.8M86.61M102.2M110.52M191.83M144.87M129.18M122.38M109.62M154.2M89.77M92.05M194.29M190.95M
Total Debt2.04M2.32M3.87M5.27M157.75M195.49M78M94.92M83.18M99.13M87.02M89.87M74.07M8.58M33.86M42.05M53.51M62.51M133.08M39.45M21.53M25.43M42.27M93.74M42.81M48.87M157.27M0
Net Debt-103.54M-106.42M-77.76M-11.83M154.14M194.45M76.4M93.89M67.16M73.6M66.39M87.42M69.08M521K23.4M31.4M42.56M53.91M122.91M30.38M21.53M25.43M42.27M93.74M25.6M46.22M157.27M-4.83M
Debt / Equity0.01x0.01x0.01x0.01x0.35x0.66x0.50x0.58x0.38x0.42x0.57x0.64x0.57x0.05x0.16x0.17x0.22x0.25x0.57x0.10x0.06x0.07x0.12x0.29x0.14x0.18x1.28x-
Debt / EBITDA-0.39x0.17x6.10x0.04x0.56x1.31x189.79x--4.52x5.66x3.14x---2.02x4.36x2.05x-0.78x0.61x0.68x0.96x1.67x0.66x0.87x3.59x-
Net Debt / EBITDA19.94x-7.98x-122.46x-0.09x0.55x1.31x185.89x--3.36x4.32x3.05x---1.51x3.47x1.77x-0.60x0.61x0.68x0.96x1.67x0.39x0.82x3.59x-0.21x
Interest Coverage-37.00x-1.56x-0.33x13.71x18.59x21.13x5.65x1.67x-2.22x2.02x5.26x3.97x-6.53x-10.82x-10.49x2.27x-0.91x2.89x-47.33x16.24x19.24x8.21x9.08x11.19x15.34x2.75x1.87x-
Total Equity312.81M322.82M418.96M473.39M457.22M297.53M154.91M163.5M218.2M237.72M151.8M141.34M130.33M178.05M209.12M249.3M246.01M246.07M234.02M390.44M374.86M359.29M346.37M320.52M300.83M269.93M123.34M118.74M
Equity Growth %-58.16%-22.95%-11.5%3.54%53.67%92.07%-5.25%-25.07%-8.21%56.6%7.4%8.45%-26.8%-14.86%-16.12%1.34%-0.03%5.15%-40.06%4.16%4.33%3.73%8.07%6.55%11.45%118.85%3.87%-
Book Value per Share9.949.9612.5513.3412.187.964.294.576.126.574.194.394.185.746.787.997.927.947.5512.0211.4510.9610.639.858.9410.705.325.12
Total Shareholders' Equity312.81M322.82M418.96M473.39M457.22M297.53M154.38M162.63M217.53M237.09M151.24M140.85M129.88M178.05M209.12M249.3M246.01M246.07M234.02M390.44M374.86M359.29M346.37M320.52M300.83M269.93M123.34M118.74M
Common Stock3K3K3K4K4K4K4K4K4K4K3K3K3K3K3K3K3K3K3.08K3.16K3.21K3.21K3.22K3.18K3.22K3.22K2.32K0
Retained Earnings118.94M123.21M218.06M238.36M165.73M-22.73M-154.74M-141.78M-84.06M-67.11M-104.09M-112.06M-116.47M-67.31M-32.72M9.5M5.4M8.18M1.48M144.43M120.58M103.94M89.19M68.53M42.71M12.93M4.26M0
Treasury Stock0000000000000000000000000000
Accumulated OCI-1.69M-1.56M-1.44M-1.39M-1.39M-1.29M-1.28M-1.24M-1.46M-1.17M-1.24M-1.21M-1.12M-970K-3.08M-3.37M-2.4M-2.98M-4.83M163.24K-20M-15.39M-10.51M-17.25M-371.69K-1.16M-5.02M0
Minority Interest000000534K868K670K630K559K496K454K000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Structural Revenue Normalization

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Asset Base Contraction Reflects Normalization

According to recent financial filings, CCRN's total assets have declined from $679.3M in 2023Q4 to $451.1M in 2026Q1, signaling a deliberate reduction in the balance sheet footprint as the company adjusts to the post-pandemic contraction in demand for contingent healthcare staffing services across its core markets.

The reduction in total assets appears to be a direct consequence of the company's efforts to right-size its operations following the pandemic-era peak. This trend suggests that management is prioritizing capital preservation over expansion, which may be a prudent strategy given the current negative operating margin environment.

Robust Liquidity Buffers Against Volatility

Based on reported figures, CCRN maintains a strong liquidity position with $105.6M in cash as of 2026Q1 and a current ratio of 3.29, providing a significant buffer against the ongoing revenue contraction and the operational challenges inherent in the current healthcare staffing market cycle.

The company's ability to maintain a high current ratio despite declining revenue suggests that working capital management remains a core strength. This liquidity provides management with the flexibility to navigate prolonged industry headwinds without the immediate need for external financing or dilutive capital raises.

Minimal Leverage Enhances Financial Flexibility

As reported in financial statements, CCRN maintains a negligible debt-to-equity ratio of 0.01% as of 2026Q1, with total debt standing at only $2.0M, which effectively insulates the company from interest rate volatility and provides a clean balance sheet for potential future strategic capital allocation.

The near-absence of debt is a critical defensive feature that distinguishes CCRN from more leveraged peers in the staffing industry. This conservative capital structure suggests that the company is well-positioned to weather the current downturn without the pressure of debt service obligations impacting its cash flow.

Goodwill Impairment Risks Remain Prevalent

According to historical balance sheet data, CCRN's goodwill balance dropped from $135.1M in 2025Q3 to $63.8M in 2026Q1, indicating that the company has already recognized significant impairment charges that may reflect a downward revision in the long-term valuation of past acquisitions in a normalizing market.

Investors should monitor whether further goodwill write-downs are necessary if the current revenue contraction persists beyond initial expectations. The significant reduction in intangible assets suggests that the carrying value of previous investments is being aggressively aligned with current, more conservative market realities.

CCRN — Frequently Asked Questions

Quick answers to the most common questions about buying CCRN stock.

What are the total assets of Cross Country Healthcare, Inc. (CCRN)?

As of 2025, Cross Country Healthcare, Inc. (CCRN) had total assets of $449.0M including $293.6M in current assets.

How much debt does Cross Country Healthcare, Inc. (CCRN) have?

Cross Country Healthcare, Inc. (CCRN) carries total debt of $2.3M, offset by $108.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of Cross Country Healthcare, Inc.?

Cross Country Healthcare, Inc. (CCRN) has total shareholders' equity (book value) of $322.8M ($9.96 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is Cross Country Healthcare, Inc.'s current ratio and liquidity?

Cross Country Healthcare, Inc. (CCRN) reported a current ratio of 3.78x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.